Christoffer Polcwiartek Selected Research

Christoffer Polcwiartek Research Topics

Disease

9	Schizophrenia (Dementia Praecox) 02/2022 - 03/2015
6	Heart Failure 01/2022 - 12/2018
4	Myocardial Infarction 07/2022 - 05/2016
4	Atrial Fibrillation 11/2021 - 11/2019
3	Heart Diseases (Heart Disease) 01/2022 - 01/2020
3	Mental Disorders (Mental Disorder) 01/2021 - 01/2019
2	COVID-19 02/2022 - 01/2021
2	Out-of-Hospital Cardiac Arrest 01/2022 - 01/2019
2	Bipolar Disorder (Manic Depressive Psychosis) 10/2021 - 01/2021
2	Stroke (Strokes) 01/2021 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 11/2019
2	Hyperkalemia 12/2018 - 01/2018
2	Hypokalemia 12/2018 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 01/2017 - 10/2016
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2017 - 10/2016
2	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2017 - 10/2016
2	Myocarditis (Carditis) 05/2016 - 03/2016
2	Brugada Syndrome 05/2016 - 09/2015
2	Torsades de Pointes (Torsade de Pointes) 05/2016 - 09/2015
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 05/2016 - 09/2015
1	Myocardial Ischemia (Ischemic Heart Diseases) 07/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2022
1	Epilepsy (Aura) 01/2022
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 12/2021
1	Neoplasms (Cancer) 12/2021
1	Depressive Disorder (Melancholia) 01/2021
1	Cardiac Arrhythmias (Arrythmia) 11/2020
1	Stable Angina 10/2020
1	Acute Coronary Syndrome 01/2020
1	Bundle-Branch Block (Fascicular Block) 11/2019
1	Hypocalcemia 01/2019
1	Hypercalcemia (Milk Alkali Syndrome) 01/2019
1	Learning Disabilities (Learning Disability) 12/2018
1	Borderline Personality Disorder (Personality Disorders, Borderline) 12/2018
1	Latent Autoimmune Diabetes in Adults 10/2016
1	Drug-Related Side Effects and Adverse Reactions 10/2016
1	Weight Gain 10/2016
1	Psychotic Disorders (Schizoaffective Disorder) 03/2016
1	Agranulocytosis (Granulocytopenia) 03/2016

Drug/Important Bio-Agent (IBA)

8	Antipsychotic Agents (Antipsychotics)IBA 10/2021 - 09/2015
5	Psychotropic Drugs (Psychoactive Drugs)IBA 10/2021 - 01/2019
5	PotassiumIBA 01/2021 - 01/2018
3	Clozapine (Clozaril)FDA LinkGeneric 12/2018 - 03/2016
2	Antidepressive Agents (Antidepressants)IBA 01/2022 - 10/2021
2	Anticonvulsants (Antiepileptic Drugs)IBA 10/2021 - 12/2018
2	CalciumIBA 01/2021 - 01/2019
2	Angiotensin Receptor AntagonistsIBA 01/2021 - 01/2019
2	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2021 - 01/2019
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 01/2019
2	Pharmaceutical PreparationsIBA 03/2016 - 09/2015
1	Alanine Transaminase (SGPT)IBA 02/2022
1	TroponinIBA 02/2022
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2022
1	Levetiracetam (Keppra)FDA LinkGeneric 01/2022
1	Mirtazapine (Rexer)FDA LinkGeneric 01/2022
1	Lamotrigine (Lamictal)FDA LinkGeneric 01/2022
1	Citalopram FDA LinkGeneric 01/2022
1	Fluorouracil (Carac)FDA LinkGeneric 12/2021
1	LithiumIBA 10/2021
1	P 536IBA 01/2020
1	DiureticsIBA 01/2020
1	omega-Chloroacetophenone (Mace)IBA 01/2020
1	Amiodarone (Amiodarona)FDA LinkGeneric 11/2019
1	ElectrolytesIBA 01/2019
1	insulin receptor-related receptor (IRR)IBA 01/2019
1	SodiumIBA 12/2018
1	Central Nervous System StimulantsIBA 01/2018
1	Insulin (Novolin)FDA Link 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Olanzapine (Zyprexa)FDA Link 03/2016
1	Fluvoxamine (Luvox)FDA LinkGeneric 03/2016
1	Quetiapine Fumarate (Seroquel)FDA Link 03/2015
1	sertindole (Serdolect)IBA 03/2015

Therapy/Procedure

3	Percutaneous Coronary Intervention 07/2022 - 01/2020
3	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 07/2022 - 01/2019
2	Therapeutics 01/2020 - 01/2020
1	Catheter Ablation 11/2021
1	Electric Countershock (Cardioversion) 01/2021
1	Heart-Assist Devices 11/2020
1	Transplantation 11/2020
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 11/2019
1	Cardiac Resynchronization Therapy 11/2019
1	Duration of Therapy 10/2016